Kirpekar Sahil 4
4 · ATAI Life Sciences N.V. · Filed Mar 24, 2025
Insider Transaction Report
Form 4
Kirpekar Sahil
Chief Business Officer
Transactions
- Sale
Common Shares
2025-03-21$1.35/sh−48,563$65,560→ 115,636 total
Footnotes (1)
- [F1]Represents shares sold to satisfy the Reporting Person's tax liability on vesting of restricted stock units.